Uncategorized

Stipple Bio launches with $100M to find more precise targets on cancer proteins

Published

1 day ago

on

It’s no secret that cancer drug development is full of bandwagons. Companies see a promising target, and crowd around it (see PD-1xVEGF or HER2 for recent examples).

But two cancer biologists — Aaron Ring at the …

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version